VitalStone Financial »

Crispr Therapeutics shares owned by VitalStone Financial

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by VitalStone Financial from 13F filings

Historical chart of VitalStone Financial investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by VitalStone Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by VitalStone Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.0k 102 58.82
2023-09-30 $5.0k 102 49.02
2023-06-30 $0 129 0.00
2023-03-31 $15k 192 78.13
2022-12-31 $7.8k 125 62.50

More positions owned by VitalStone Financial

Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Invesco Qqq Trust Series I Etf (QQQ)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Ft Cboe Vest Fund Of Buffer Etfs Etf (BUFR)
Ishares Core S&p Small Cap Etf Etf (IJR)
Vaneck Clo Etf Etf (CLOI)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Vaneck Morningstar Wide Moat Etf Etf (MOAT)
Vanguard Value Etf Etf (VTV)
Invesco Optimum Yield Diversified Commodity Strategy No K-1 Etf Etf (PDBC)
Invesco Ultra Short Duration Etf Etf (GSY)
Ishares National Muni Bond Etf Etf (MUB)
Vaneck Oil Services Etf Etf (OIH)
Vanguard Growth Etf Etf (VUG)
Ishares Global Tech Etf Etf (IXN)

View all positions for VitalStone Financial

Top funds holding Crispr Therapeutics

ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics